US Bancorp
IMI

US Bancorp’s Intermolecular, Inc. IMI Stock Holding History

US Bancorp’s Portfolio IMI Stock Details IMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-16,840
Closed -$25K – 3679
2016
Q2 		$25K Hold
16,840
– – ﹤0.01% 2720
2016
Q1 		$43K Buy
+16,840
New +$38K ﹤0.01% 2457

Other funds holding IMI

RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
SPM
Symmetry Peak Management Radnor, Pennsylvania $369M AUM 148.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $12.6B AUM 31.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
SIM
Spark Investment Management New York $51.2M AUM 87.14% 1-Year Est. Return

US Bancorp's IMI Position: Q3 2016 in Review

US Bancorp sold out of Intermolecular, Inc. (IMI) in Q3 2016, closing a stake of 16,840 shares — an estimated $25K sold.

US Bancorp first reported a position in IMI in Q1 2016 and held it in 2 quarters. The position peaked at $43K in Q1 2016. 28 funds tracked by Wall St. Rank hold IMI as of Q3 2016.

  • US Bancorp reported no remaining Intermolecular, Inc. position as of Q3 2016 after selling out during the quarter.
  • US Bancorp sold 16,840 Intermolecular, Inc. shares in Q3 2016, an estimated $25K.
  • US Bancorp first reported a position in Intermolecular, Inc. in Q1 2016 and held it in 2 quarters.
  • US Bancorp's Intermolecular, Inc. position peaked at $43K in Q1 2016.
  • 28 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q3 2016.

Based on US Bancorp's 13F filing for Q3 2016, filed 4 Nov 2016.